Projects per year
Personal profile
Biography
Consultant neurologist and MS specialist at Monash Health since 2021 and head of the MS service from January, 2022. I am also an honorary senior lecturer at Monash University. I completed my PhD on metabolic MRI markers in progressive multiple sclerosis in December 2021. My research skills are in the application of advanced neuroimaging techniques in clinical trial cohorts, optical coherence tomography analysis, clinical trial design, diagnosis of adult-onset leukodystrophy and treatment sequencing in MS.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Neurosciences, PhD, Investigating brain metabolism in multiple sclerosis to examine mechanisms of injury and disability using magnetic resonance spectroscopy, University College London
Sept 2017 → 28 Dec 2021
Award Date: 28 Dec 2021
Medicine, MBBS, Bachelor of Medicine, Bachelor of Surgery, University of Adelaide
Award Date: 14 Dec 2009
Research area keywords
- neurology
- Magnetic Resonance Imaging (MRI)
- Multiple Sclerosis (MS)
- neuroinflammation
- Clinical Trials
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pregnancy and the multiple sclerosis brain
John, N. (Primary Chief Investigator (PCI)), Beadnall, H. N. (Chief Investigator (CI)), Jokubaitis, V. (Associate Investigator (AI)), Butzkueven, H. (Associate Investigator (AI)), Phan, T. (Associate Investigator (AI)), Palmer, K. (Associate Investigator (AI)), Egan, G. (Associate Investigator (AI)) & Shipley, J. M. (Associate Investigator (AI))
1/01/25 → 31/12/28
Project: Research
-
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB AS MONOTHERAPY OR IN ADDITION TO BASELINE THERAPY IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE (MOGAD)
John, N. (Primary Chief Investigator (PCI))
20/05/24 → 19/05/29
Project: Research
-
Applying OCCAMS molecular razor to study the role of EBV in MS pathogenesis
Phan, T. (Primary Chief Investigator (PCI)), Massey, J. (Chief Investigator (CI)), Yazar, S. (Chief Investigator (CI)), Goodnow, C. (Chief Investigator (CI)), Jackson, K. J. L. (Chief Investigator (CI)), Hewitt, A. W. (Chief Investigator (CI)), Bruestle, A. (Chief Investigator (CI)), Desborough, J. L. (Chief Investigator (CI)), Zaunders, J. (Chief Investigator (CI)), Parnell, G. P. (Chief Investigator (CI)), Palendira, U. (Chief Investigator (CI)), John, N. (Chief Investigator (CI)), Ballouz, S. (Chief Investigator (CI)), Tscharke, D. C. (Chief Investigator (CI)), Deenick, E. K. (Chief Investigator (CI)), Rickinson, A. B. (Associate Investigator (AI)), Boyd, S. D. (Associate Investigator (AI)), Schwab, N. (Associate Investigator (AI)), Petoumenos, K. (Associate Investigator (AI)), Garber, J. (Associate Investigator (AI)), Swaminathan, S. (Associate Investigator (AI)), Singh, M. (Associate Investigator (AI)), Kermode, A. (Associate Investigator (AI)), Sutton, I. J. (Associate Investigator (AI)) & Powell, J. E. (Associate Investigator (AI))
1/01/24 → 31/12/27
Project: Research
-
Comorbidities and their role in multiple sclerosis outcomes: A cross-sectional pilot study
John, N. (Primary Chief Investigator (PCI)), Phan, T. (Chief Investigator (CI)) & Egan, G. (Chief Investigator (CI))
13/03/23 → 31/03/24
Project: Research
-
Correction to: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications (PharmacoEconomics, (2024), 10.1007/s40273-024-01417-4)
Campbell, J. A., Henson, G. J., Ngwa, V. F., Ahmad, H., Taylor, B. V., van der Mei, I., MSBase Australian Researchers & Palmer, A. J., Feb 2025, In: PharmacoEconomics. 43, 2, p. 241 1 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications
Campbell, J. A., Henson, G. J., Ngwa, V. F., Ahmad, H., Taylor, B. V., van der Mei, I., MSBase Australian Researchers & Palmer, A. J., Feb 2025, In: PharmacoEconomics. 43, 2, p. 223–239 17 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
Spelman, T., Herring, W. L., Acosta, C., Hyde, R., Jokubaitis, V. G., Pucci, E., Lugaresi, A., Laureys, G., Havrdova, E. K., Horakova, D., Izquierdo, G., Eichau, S., Ozakbas, S., Alroughani, R., Kalincik, T., Duquette, P., Girard, M., Petersen, T., Patti, F. & Csepany, T. & 45 others, , Dec 2024, In: Journal of Medical Economics. 27, 1, p. 109-125 17 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Citations (Scopus) -
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries
Sharmin, S., Roos, I., Malpas, C. B., Iaffaldano, P., Simone, M., Filippi, M., Kubala Havrdova, E., Ozakbas, S., Brescia Morra, V., Alroughani, R., Zaffaroni, M., Patti, F., Eichau, S., Salemi, G., Di Sapio, A., Inglese, M., Portaccio, E., Trojano, M., Amato, M. P. & Kalincik, T. & 2 others, , May 2024, In: The Lancet Child & Adolescent Health. 8, 5, p. 348-357 10 p.Research output: Contribution to journal › Article › Research › peer-review
12 Citations (Scopus) -
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Li, Y., Saul, A., Taylor, B., Ponsonby, A. L., Simpson-Yap, S., Blizzard, L., Broadley, S., Lechner-Scott, J., Karabudak, R., Patti, F., Eichau, S., Onofrj, M., Ozakbas, S., Horakova, D., Kubala Havrdova, E., Grand'Maison, F., Alroughani, R., Gerlach, O., Amato, M. P. & Altintas, A. & 37 others, , Jan 2024, In: Journal of Neurology. 271, 1, p. 472-485 14 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)